Question to the Ministry of Defence:

To ask the Secretary of State for Defence, pursuant to the Answer of 1 June 2015 to Question 126, when he plans to place in the Library the correspondence between 2010 and 2015 between his Department and Public Health England in relation to use of Lariam or Mefloquine and reports of (a) hallucinations, (b) psychosis and (c) suicidal thoughts in personnel prescribed those medications.

The Department does not hold any correspondence between Public Health England (PHE) and the Ministry of Defence (MOD) in relation to hallucinations, psychosis or suicidal thoughts in personnel prescribed Mefloquine (commercial name Lariam).

The use of Mefloquine by the MOD is based on the expert guidance of the PHE Advisory Committee on Malaria Prevention on which the MOD has a representative.